Details of the Drug Reposition

General Information of This Drug (ID: DMV9QGW)

Drug Name
BPX-601   DMV9QGW
Drug Type
CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Phase 1/2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Gastric adenocarcinoma DISWWLTC 2B72 Phase 1/2 [1]
Pancreatic cancer DISJC981 2C10 Phase 1/2 [1]
Prostate cancer DISF190Y 2C82.0 Phase 1/2 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT02744287) Use of Ligand-Inducible Autologous T Cells Engineered to Target PSCA on Tumor Cells in Selected Advanced Solid Tumors